Pharmaceutical Medicine

Gen-Tropin AQx® is Bio-Gen pharma�s human growth hormone product (somatropin). It is produced using recombinant DNA technology and it is identical to human growth hormone produced naturally in the human body. Gen-Tropin AQx® is prepared in a ready to use liquid formulation and supplied in 10mg(30IU) cartridges.
Gen-Tropin AQx® is supplied in:
10mg (30 International Units) of GH in sterile and stable liquid formulation per single Gen-Tropin AQx®.
Each Gen-Tropin AQx® carton contain 5 cartridges of 3ml containing 10mg(30IU) of GH [somatropin].
Cartridges are foil sealed in plastic tray in sets of 5.
Each cartridge is printed with storage, safety and contact information.
GH should not be used for pediatric treatment if patient�s growth plates (epiphyses) are closed.
Active proliferative or severe non-proliferative diabetic retinopathy.
GH should not be used in patients with any evidence of any tumor.
GH should not be used in patients pre-existing or active malignancy.
GH should not be used in patients with complication due to open heart or abdominal surgery and with acute respiratory failure
GH is contraindicated in severely obese patients or with respiratory impairments GH is contraindicated in patients with Prader-Willi syndrome who are severely obese or have severe respiratory impairment.
Gen-Tropin AQx® [somatropin] is not indicated for children with growth failure due to genetic Prader-Willi syndrome.
Read more in prescribing information leaflet.